PlainRecalls
FDA Drug Moderate Class II Ongoing

Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons)

Reported: April 16, 2025 Initiated: March 21, 2025 #D-0357-2025

Product Description

Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons)

Reason for Recall

Lack of Assurance of Sterility: Media fill with bacterial contamination

Details

Units Affected
23,960 vials
Distribution
U.S. Nationwide
Location
Bengaluru, N/A

Frequently Asked Questions

What product was recalled?
Haloperidol Decanoate Injection 100mg/mL, 1mL Single-Dose Vial, Rx Only, Manufactured by: Somerset Therapeutics Limited, Kamataka, India, Manufactured for: BluePoint Laboratories NDC 68001-581-41 (individual carton) and NDC 68001-581-48 (5x1 mL cartons). Recalled by Somerset Therapeutics Private Limited. Units affected: 23,960 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Media fill with bacterial contamination
Which agency issued this recall?
This recall was issued by the FDA Drug on April 16, 2025. Severity: Moderate. Recall number: D-0357-2025.